SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation as CEO and CFO Colette Kresss appointment as interim leader dominate discussion. Traders debate whether Nvidia can execute without its founder, with some concerned about leadership and governance risks while others call the selloff an overreaction and buy the dip, citing the companys AI business and upcoming earnings.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Traders are linking SMCIs sharp decline to reports and speculation about DOJ scrutiny involving Super Micro, Nvidia and Megaspeed over alleged chip diversion to China, as well as uncertainty around Nvidia CEO Jensen Huang and SMCIs close Nvidia ties. Some see the move as an overreaction and a buying opportunity; others fear renewed compliance and governance risks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebiuss quarterly results and outlook are driving attention: despite a revenue beat, investors focused on a delayed capacity ramp, a more cautious near-term revenue outlook, and sharply higher planned capital spending. Traders are split between viewing the selloff as an overreaction given strong demand and customer prepayments, and worrying about execution delays and financing needs; weakness in Nvidia and other AI-linked stocks added pressure.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines stronger-than-expected Q3 resultsalong with record backlog, positive free cash flow, and reaffirmed growth guidanceare driving the rally and bullish re-rating discussion. Traders are also debating whether the gains can hold, citing continuing operating losses and the need to convert backlog into sustained cash generation, while some speculate about short covering.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Jensen Huangs resignation and Nvidias leadership upheaval have fueled a rotation into AMD as traders speculate that customers, investment, or talent could shift toward chip rivals. The community is divided over whether the rally signals lasting market-share gains or is a temporary sympathy move, with some also warning that AMDs valuation is stretched.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

Cardinals Q3 resultsrapid revenue growth overshadowed by sharply compressed margins, a net loss, and withdrawal of its full-year outlookhave fueled a severe selloff; the Hughes Brothers acquisition was also postponed. Traders are split between blaming execution and management credibility, and viewing the decline as excessive given the companys cash position and authorized buyback.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is under pressure amid trader concerns that reported links to Megaspeed, a firm tied to allegations involving Nvidia CEO Jensen Huang, could draw scrutiny or tighter U.S. controls on advanced-chip access to China; Alibabas direct involvement remains unconfirmed. The community is split between seeing the selloff as an overreaction and fearing restricted Nvidia-chip access could hurt Alibabas AI and cloud competitiveness.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp gold selloff tied in community discussion to hotter-than-expected inflation, rising Treasury yields and a stronger dollar, which have revived expectations of tighter Fed policy and weighed on non-yielding bullion. Traders are split between calling the decline a buying opportunity or expecting more downside, with some arguing longer-term demand for gold remains supportive.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Blacklift rocket unveiling and plans to bring launch capability in-house are driving discussion, with bulls seeing a way to reduce reliance on outside launch providers. Skeptics question the rockets timeline, added spending and execution risk while BlueBird deployments and commercial service remain delayed; traders also point to elevated short interest.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas quarterly results beat expectations, with higher revenue guidance, a larger backlog and an earlier adjusted EBITDA break-even timeline driving bullish reactions. The stocks weak response has sharpened debate over compressed gross margins, cash burn and dilution, while some traders blame short selling or broader market pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investigation of MDGL Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

Investigation of MDGL Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP Investigation of MDGL Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLPPR NewswireRADNOR, Pa., Nov. 11...

MADRIGAL PHARMACEUTICALS, INC. MDGL INVESTORS: Contact Kirby McInerney LLP About the Firms Securities Investigation Following 8.1% Share Drop

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Madrigal Pharmaceuticals, Inc. (Madrigal or the Company) (NASDAQ: MDGL) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other...

MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns

MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal...

The Zacks Analyst Blog Highlights TG Therapeutics, BioCryst, Insmed and Madrigal

TGTX, BCRX, INSM and MDGL are expanding commercial reach through rising therapy sales, broader patient access and potential new indications.

4 Commercial-Stage Biotechs Poised for Sustained Revenue Growth

TGTX, BCRX, INSM and MDGL are expanding product sales through rising demand, broader patient access and new market opportunities.

MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Madrigal Pharmaceuticals, Inc. (Madrigal or the Company) (NASDAQ: MDGL) for violations of the securities laws.INVESTIGATION DETAILS: The...

Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLPPR NewswireRADNOR, Pa., Nov...

NASDAQ: MDGL INVESTIGATION ALERT: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Madrigal Pharmaceuticals, Inc. (Madrigal) (NASDAQ: MDGL) on behalf of investors who purchased or acquired Madrigal...

Lost Money on Madrigal Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 8.1% Share Price Drop

Investors who lost money on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors...

Did You Lose Money on Madrigal Pharmaceuticals, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 8.1% Share Price Decline

Investors who suffered losses on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ...

Madrigal says the U.S. F2-F3 MASH market is on track for more than 30% growth by YE26; MAESTRO-CSPH initiation is expected in the first half of 2027, subject to regulatory discussions.

Madrigal's SG&A increased with Rezdiffra commercial investment, cash and marketable securities were lower than Dec. 31, 2025, and Madrigal identifies regulatory, trial-enrollment, safety, and Rezdiffra market-acceptance risks.

Madrigal reported 50% revenue growth and net income; Rezdiffra patient counts nearly doubled and the addressable market was growing, while a new Phase 3 trial was planned and analyses found improved histology across genetic variants.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal’s MASH Drug Shows Improvements In Liver Health Across 4 Studies, Days After Company Disclosed $1.1B Rezdiffra Sales 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>In the Truveta study, 55% of patients experienced at least a 25% reduction in liver stiffness after one year, while 93% saw their condition improve or remain stable.</li><li>On Wednesday, Madrigal disclosed that a former executive filed a whistleblower complaint, alleging retaliation after raising concerns about certain data and reporting practices.</li><li>Earlier this week, Madrigal reported its first profitable quarter.</li></ul><p>Madrigal Pharmaceuticals (MDGL) was on investors’ radar on Thursday, after the company reported encouraging real-world data for Rezdiffra, its lead drug for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can lead to scarring, liver failure, and cancer.</p><p>Across four studies, 37% to 55% of patients experienced at least a 25% improvement in liver stiffness after about one year of treatment.</p><p>At the time of writing,&nbsp;<a class="mention" data-mention="$MDGL" data-symbol-id="MDGL" href="https://stocktwits.com/symbol/MDGL" target="_blank">MDGL shares</a> traded marginally lower while the State Street SPDR S&amp;P Biotech ETF (XBI) was down 5%.</p><p><a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, which tracks the S&amp;P 500, slumped 3.5%; the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> was down 2.5%; and the tech-heavy<a href="https://stocktwits.com/symbol/QQQ">&nbsp;Invesco QQQ Trust (QQQ)</a> crashed 5.5%.</p><h2 class="st-heading-2">What Did The Real World Studies Show?</h2><p>The findings across four separate studies showed consistent improvements in liver health among patients receiving the drug. In the Truveta study, 55% of patients experienced at least a 25% reduction in liver stiffness after one year, while 93% saw their condition improve or remain stable.</p><p>Similar results were observed in the Trio Health and Gastro Health studies, where 45% and 47% of patients, respectively, achieved at least a 25% reduction in liver stiffness. Meanwhile, a smaller study conducted at Methodist Dallas Medical Center found that 37% of patients experienced at least a 25% improvement in liver stiffness, while 83% showed improvement or remained stable.</p><p>“The findings also provide encouraging evidence that most patients are staying on therapy over time,” said chief medical officer David Soergel.</p><h2 class="st-heading-2">Whistleblower Complaint Over Data And Reporting Practices</h2><p>The positive data followed Madrigal’s<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.madrigalpharma.com/node/17766/ixbrl-viewer">&nbsp;disclosure</a> on Wednesday that former executive Michael Charlton filed a whistleblower complaint in October, alleging retaliation after raising concerns about certain data and reporting practices. Madrigal said it disputes the allegations and plans to vigorously defend itself.</p><p>However, H.C. Wainwright said available clinical evidence does not substantiate the allegations, according to The Fly.</p><h2 class="st-heading-2">Rezdriffa Sales Cross $1B&nbsp;&nbsp;</h2><p>Earlier this week, Madrigal<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.madrigalpharma.com/news-releases/news-release-details/madrigal-pharmaceuticals-reports-third-quarter-2026-financial">&nbsp;reported</a> its first profitable quarter, with third-quarter (Q3) revenue jumping 50% to $431.3 million, driven by growing Rezdiffra demand. Earnings came in at $1.83 per diluted share, compared to consensus estimates of a $ 0.87-per-share loss. Rezdiffra’s year-to-date sales surpassed $1.1 billion.</p><p>Following the earnings report, Truist raised MDGL’s price target to $743, representing an 82% upside from current levels. Canaccord also raised its price target for the stock, adding that Q3 Rezdiffra sales beat its forecast.</p><h2 class="st-heading-2">Retail Remains ‘Extremely Bullish’ On MDGL</h2><p>Retail sentiment surrounding MDGL on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.</p><p>The stock has shed around 32% so far in 2026.</p><p><strong>Also read:</strong><a href="https://stocktwits.com/news-articles/markets/equity/xeris-ceo-sees-recorlev-nearing-1b-in-annual-sales-xers-stock/cNG1kiMR94R"><strong>&nbsp;Xeris CEO Sees Recorlev Nearing $1B In Annual Sales 3 To 4 Years Earlier Than Expected – XERS Stock On Track To Hit Over 7-Year Highs</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, Madrigal Pharmaceuticals logo is seen on a smartphone screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Across four studies, 37% to 55% of patients experienced at least a 25% improvement in liver stiffness after about one year of treatment

SPDR S&P Biotech ETF

Nvidia ($NVDA) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Stocktwits

) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Current Price	$431.26
Prev Close	$433.03
Open	$433.63
Dividend Yield	0.00%
50-Day Moving Average	$480.46
Beta	0.79
Avg. Volume	296,241.84
PE Ratio	-72.46

52-Week High	$615.00
52-Week Low	$353.54
Market Capitalization	$10.06B
EPS (Annual)	-$12.85
Price to Book	16.04
Revenue Per Employee	$1.05M

Feed

News

Sentiment

Earnings

Fundamentals

Info

MDGL Fundamentals